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DObjective: To determine the influence of silent and symptomatic cerebral embolism on outcome of urgent/emer-
gent surgery after acute infective endocarditis (AIE).
Methods: From a total of 1571 patients with AIE admitted to our institution betweenMay 1995 andMarch 2012
about one-quarter (375 patients; mean age, 61.8  13.6 years) presented with cerebral embolism confirmed by
cranial computed tomography. Isolated aortic valve endocarditis was present in 165 patients (44%), 132 patients
(36%) had isolated AIE of the mitral valve, and 64 (17%) patients had left-sided double valve endocarditis.
Results:Although the majority of patients presented with neurologic symptoms, 1 out of 3 patients experienced
a so-called silent asymptomatic cerebral embolism or transient ischemic attack (n¼ 135). The rate of silent em-
bolism was equivalent in patients with isolated aortic valve versus isolated mitral valve endocarditis (37% vs
34%; P¼ .54). Comparing patients with silent embolism versus symptomatic embolism, 18 patients with silent
embolism versus 12 patients with symptomatic embolism developed postoperative hemiparesis (P¼ .69). Three
versus 4 had severe postoperative intracerebral bleeding (P¼ .71). Median follow-up of survivors with cerebral
embolism was 4.1 years (935 cumulative patient-years). Hospital mortality was 21.4% versus 19.6% (P¼ .68),
with a long-term survival of 45% 5% versus 47% 4% at 5 years (P¼ .83) and 40% 6% versus 32%
5% at 10 years (P¼ .86). Independent risk factors of mortality were age at surgery (P<.01), chronic obstructive
pulmonary disease (P¼ .01), preoperative requirement of catecholamines (P¼ .02), dialysis (P<.01), and dura-
tion of cardiopulmonary bypass (P<.01).
Conclusions: Survival after surgery for AIE is significantly impaired once cerebral embolism has occurred;
however, it does not differ in patients with symptomatic versus silent cerebral embolism. Routine computed to-
mography scans are therefore mandatory due to the high incidence of asymptomatic cerebrovascular embo-
lism—which appears to be equally as dangerous as symptomatic embolism. (J Thorac Cardiovasc Surg
2014;147:1837-46)Cerebrovascular embolic events in the setting of acute
infective endocarditis (AIE) are frequent and have been pro-
posed to impair short- and long-term survival.1,2 In
particular, hemorrhagic transformation of septic embolic
cerebral lesions during full heparinization for
cardiopulmonary bypass or after mechanical valve
replacement is rare but feared because it increases the risk
of devastating intracranial hemorrhage.
Cerebrovascular manifestations of AIE often cause the
first symptoms; that is, transient or persistent hemiparesise Department of Cardiac Surgery, Heart Center Leipzig, University of Leip-
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The Journal of Thoracic and Caror hemiplegia or even unspecific headache, meningitis,
altered level of consciousness, or severe seizures. Accord-
ing to the current practice guidelines for the management
of AIE,3,4 preoperative cerebral imaging should be
obtained to rule out septic embolic lesions, which carry a
high risk for hemorrhagic transformation. However,
asymptomatic so-called silent cerebral embolism has been
previously described and its influence on short- and long-
term outcome compared with symptomatic embolism is
controversial. Asymptomatic lesions may be missed if
routine preoperative computed tomography (CT) scans
are not obtained, and fatal neurologic injury due to hemor-
rhagic transformation may cause excessive early mortality.
Moreover, risk factors identifying patients who are at the
highest risk for cerebral embolism may pose an additional
decision: should CT scans should be obtained even in
asymptomatic patients?5
With our study we intended to determine the incidence of
cerebral embolism in cardiac surgical patients with AIE and
to investigate the predictors of unfavorable short- and long-
term outcome after surgery for infective endocarditis
complicated by cerebral embolism.diovascular Surgery c Volume 147, Number 6 1837
Abbreviations and Acronyms
AIE ¼ acute infective endocarditis
CT ¼ computed tomography
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DPATIENTS AND METHODS
A review of our institutional database identified 1571 consecutive pa-
tients who underwent operation for infective endocarditis from May
1995 throughMarch 2012. Clinical data were derived from our institutional
database and patient records. The local ethics committee did not require
additional individual patient consent.
Infective endocarditis was diagnosed by the modified Duke criteria6 and
vegetations were classified by transthoracic or transesophageal echocardi-
ography. Vegetations were measured in a minimum of 2 planes and the
maximum length of the vegetations was used. Blood cultures were
routinely taken on admission and at the first postoperative day. Routine pre-
operative cranial, thoracic, and abdominal CT scans were performed in all
patients admitted with the diagnosis of AIE to preoperatively rule out septic
embolic lesions. Overall, 375 patients (24%) presented with confirmed
cerebral embolism. Mean age was 61.8  13.6 years. Two hundred sixty-
six patients were men (70.9%). A detailed summary of the clinical data
is presented in Table 1.
Antibacterial Therapy
In all patients, empiric antibiotic treatment was immediately initiated
after diagnosis. A preoperative antibiotic therapy was initiated in 1260
out of 1571 patients (80%) and in 338 out of 375 patients (89%)TABLE 1. Baseline patient characteristics
Variable All patients (n ¼ 1571) Cerebral em
Age, y 61.6  14.8 61.8  1
Female,% 477 (30)
LVEF,% 56.1  12.6 56.
Risk factors
Hypertension 971 (62)
History of smoking 445 (28)
Diabetes 519 (33)
COPD 184 (12)
Hyperlipidemia 430 (27)
Preoperative dialysis 109 (7)
LCO preoperative 170 (11)
Logistic EuroSCORE, mean 36.2  25.8 43.
Affected valve
Single aortic 732 (47)
Single mitral 487 (31)
Aortic and mitral 223 (15)
Kissing mitraly 201 (13)
Tricuspid valve 108 (7)
Pulmonary valve 24 (2)
Vegetation size, mm
<5 300 (19)
5 to<10 276 (18)
10 940 (60)
N/A 55
Prosthetic valve endocarditis 383 (24)
Previous cardiac surgery 435 (28)
Values are presented as mean  SD or n (%). LVEF, Left ventricular ejection fraction; C
N/A, not applicable. *Range. yEndocarditis affecting the anterior leaflet of the mitral valv
1838 The Journal of Thoracic and Cardiovascular Surwith cerebral embolism. In the remaining patients antibiotic treatment
was initiated immediately after surgery according to antibiotic resistance
testing.
Operative Methods
According to current guidelines, indications for surgical intervention
are large vegetations 10mm (n¼ 261; 69.6%), prosthetic valve endocar-
ditis (n ¼ 90; 24%), abscess formation, fungal infection, Staphylococcus
aureus endocarditis (n ¼ 143; 38.1%), congestive heart failure (n ¼ 53;
14.1%), or failure of medical treatment.3
In patients requiring aortic valve replacement, most patients received
either a stented bioprosthetic valve (n ¼ 141) or a stentless bioprosthetic
valve (n ¼ 30). A homograft was used in 11 patients, and 11 patients
received a mechanical valve. In 7 patients, a reconstruction of the native
valve was possible (3.8%).
Among all patients with cerebral embolism, urgent mitral valve surgery
was required in 222 out of 375 patients (59.2%) and the patients received
mostly valve replacement with a biological (n ¼ 134) or a mechanical
(n ¼ 60) valve. In 15 patients, the mitral valve was amenable for repair.
Concomitant repair of the tricuspid aortic valve was necessary in 22 pa-
tients, whereas 9 patients required tricuspid valve replacement. Other
concomitant procedures were coronary artery bypass grafting in 66 patients
(18%), replacement of the ascending aorta in 17 patients (5%), and partial
arch replacement in 3 patients (1%). Further operative details are listed in
Table 2.
Follow-up
Our institutional database is continuously and prospectively maintained
by research personnel. Follow-up data for long-term survival or adversebolism (n ¼ 375) No cerebral embolism (n ¼ 1196) P value
3.6 (12-88)* 61.5  15.2 .78
109 (29) 368 (31) .56
7  12.0 55.9  12.7 .44
233 (62) 738 (62) .95
109 (29) 336 (28) .74
128 (34) 391 (33) .62
40 (11) 144 (12) .52
87 (23) 343 (29) .04
25 (7) 84 (7) .91
53 (14) 117 (10) .02
1  25.4 34.0  25.6 <.01
165 (44) 567 (47) .26
132 (36) 355 (30) .05
64 (17) 159 (13) .07
51 (14) 150 (13) .60
12 (3) 96 (8) <.01
2 (1) 22 (2) .09
37 (10) 263 (22) <.01
72 (19) 204 (17) .35
261 (70) 679 (57) <.01
5 50 —
90 (24) 293 (25) .89
102 (27) 333 (28) .84
OPD, chronic obstructive pulmonary disease; LCO, low cardiac output syndrome;
e as well as the aortic valve.
gery c June 2014
TABLE 2. Intraoperative data
All patients (n ¼ 1571) Cerebral embolism (n ¼ 375) No cerebral embolism (n ¼ 1196) P value
CPB time, min 129  71 128  76 129  69 .35
Minimal temp, C 32.6  2.3 32.8  2.3 32.5  2.3 <.01
Procedures
Aortic valve replacement 1017 (65) 239 (64) 778 (65) .66
Aortic valve repair 19 (1) 7 (2) 12 (1) .18
Mitral valve replacement 705 (45) 194 (52) 511 (43) <.01
Mitral valve repair 113 (7) 15 (4) 98 (8) <.01
Tricuspid valve replacement 40 (3) 3 (1) 37 (3) .01
Tricuspid valve repair 118 (8) 22 (6) 96 (8) .06
Concomitant procedures
CABG 260 (17) 66 (18) 194 (16) .23
Replacement of the ascending aorta 74 (5) 17 (5) 57 (5) 1.0
Partial arch replacement 15 (1) 3 (1) 12 (1) 1.0
Values are presented as mean  standard deviation or n (%). CPB, Cardiopulmonary bypass; CABG, coronary artery bypass grafting.
Misfeld et al Acquired Cardiovascular Disease
A
C
Doutcomes are routinely gained either by direct telephone interview with the
patient, a close relative, or the referring physician.
Statistical Methods
Characteristics are described as means  standard deviations. Contin-
uous data were analyzed using the Wilcoxon log-rank test or Mann-
WhitneyU test. Long-time survival analysis was performed by calculating
Kaplan-Meier life tables. Groups were compared using the log-rank test.
Categorical data were analyzed using c2 or Fisher exact test. All tests
were performed 2-sided. Risk factors for cerebral embolism and hospital
mortality were identified using a multivariable binary regression analysis.
The linearized mortality rate was calculated as 100 times the total number
of deaths divided by the total person-years of follow-up. Follow-up time for
survival was measured from the date of the operation to either the date of
death or the date of the last alive contact. The Cox proportional hazards
model was used to examine the risk factors for long-term death. The as-
sumptions of the proportional hazards model were checked graphically.
Univariable risk factors with a P value<.1 were included in the multivari-
able analysis.
RESULTS
Overall mean follow-up time of the entire cohort of pa-
tients admitted with AIE and cerebral embolism
(N ¼ 375) was 3.1  3.8 years, with a maximum follow-
up time of 16.9 years. An isolated left-sided endocarditis
was present in 362 patients (96.5%), whereas 3.5% had
either right-sided endocarditis or combined left- and right-
sided endocarditis. Ninety patients had prosthetic valve
endocarditis (24%). One hundred sixty-five patients
(44%) had single aortic valve endocarditis, whereas 133 pa-
tients (35.5%) had single mitral valve endocarditis. Com-
bined affliction of the aortic and the mitral valve was
present in 64 patients (17.1%). One hundred two patients
had previously undergone cardiac surgery (27.2%). About
23.5% of patients with prosthetic valve endocarditis had
cerebral embolism; 37.8% of those were asymptomatic.
Causative Pathogens
In most patients, S aureus was the causative pathogen for
AIE (n ¼ 143; 38.1%), followed by streptococci in 78The Journal of Thoracic and Carpatients (21%) and Enterococcus faecalis in 49 patients
(13%). Staphylococcus epidermidis was the pathogen in
25 patients (7%). Other bacteria or fungi were present in
38 patients (10%). In 42 of 375 patients, the preoperative
blood cultures were sterile (11%). S aureus was signifi-
cantly associated with an impaired prognosis compared
with patients with other pathogens: cumulative survival
was 49%  4% versus 63%  3% after 1 year (P ¼ .04)
and 38%  5% versus 51%  4% at 5 years, respectively
(P<.01).Preoperative Symptomatology
Two hundred forty out of 375 patients (64%) had symp-
tomatic cerebral embolism, whereas hemiparesis or hemi-
plegia was present in 110 patients. An altered level of
consciousness was detected in 60 patients (16%), 8 patients
experienced seizures (2%), and 11 patients had symptoms
whowere characteristic of meningitis or septic encephalitis.
Five patients experienced intracerebral bleeding (1%).Risk Factors for Cerebral Embolism in the Study
Cohort
A multivariate regression analysis identified a vegetation
size exceeding 10 mm (odds ratio [OR], 1.40; 95% confi-
dence interval [CI], 1.07-1.82; P ¼ .01), affliction of the
aortic valve (OR, 2.43; 95% CI, 1.58-3.72; P< .01) or
the mitral valve (OR, 2.76; 95% CI, 1.82-4.20; P< .01),
preoperative antibiotic therapy (OR, 1.91; 95% CI,
1.27-2.87; P< .01), and S aureus (OR, 1.89; 95% CI,
1.43-2.48; P< .01) as significant risk factors for cerebral
embolism. Age and sex were not found to be associated
with a higher risk of cerebral embolism. In patients with
vegetations <5 mm, the rate of cerebral embolism was
12.3% (n ¼ 37 out of 300) compared with 27.8% in pa-
tients with vegetations 10 mm (n ¼ 261 out of 940;
P<.01). The rate of cerebral embolism in patients with a
positive blood culture result was almost twice as high asdiovascular Surgery c Volume 147, Number 6 1839
TABLE 3. Reasons for hospital death
Reason for hospital death No. of patients (N ¼ 88)
Septic shock with multiorgan failure 32 (40)
Cerebral complications 12 (15)
Cardiac* 18 (22)
Gastrointestinal 7 (9)
Hemorrhagic shock 4 (5)
Pulmonary complications 2 (2)
Other 6 (7)
Values are presented as n (%). *Low cardiac output syndrome.
FIGURE 1. Long-term survival in patients with cerebral embolism
compared with patients without cerebral embolism. pts, Patients.
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[n ¼ 333 out of 1263] vs 13.8% [n ¼ 42 out of 305];
P<.01).
Pattern of Embolic Lesions
The incidence of further septic embolic lesions was
significantly higher in patients with cerebral embolism;
that is, almost half of patients with cerebral embolism
also experienced septic embolic lesions to the spleen
(186 out of 375; 49.1%) compared with an incidence of
22.1% in patients without cerebral embolism (294 out of
1196; P < .01). Renal lesions were detected in 24.3%
compared with 7.0% (91 out of 375 vs 84 out of 1196;
P<.01), whereas pulmonary lesions were less frequent in
patients with cerebral embolism (7 out of 375 vs 64 out of
1196; 1.9% vs 5.4%; P ¼ .04).
Hospital Mortality and Short-Term Outcome
Hospital mortality, defined as death within 30 days or in-
hospital death, was 21.6% (n¼ 81 patients), which was not
inferior to patients without cerebral embolism (hospital
mortality, 19.7%; P ¼ .51). Main reason for hospital death
was septic shock with consecutive multiorgan failure in
40% (n ¼ 32), followed by low cardiac output syndrome
in 22% (n ¼ 18 patients). A total of 15% of patients died
from cerebral complications (n ¼ 12); most from cerebral
edema (Table 3).
Risk factors identified for hospital mortality among all
patients with AIE (n¼ 81 early deaths) by multivariable bi-
nary regression analysis were female gender (OR, 1.6; 95%
CI, 1.2-2.1; P ¼ .01), age at surgery (OR, 1.03; 95% CI,
1.02-1.05; P< .01), low cardiac output syndrome (OR,
2.5; 95% CI, 1.7-3.6; P<.01), renal insufficiency requiring
dialysis (OR, 3.3; 95% CI, 2.2-5.1; P<.01), and impaired
left ventricular ejection fraction (OR, 1.3; 95% CI, 1.2-1.5;
P<.01). Cerebral embolism did not appear as a risk factor
for early mortality (OR, 1.1; 95% CI, 0.8-1.5; P ¼ .51).
Postoperative Neurologic Outcome
Postoperative neurologic outcome in patients with silent
versus symptomatic embolism was not influenced by preop-
erative symptomatology: 30 patients had postoperative
hemiparesis or hemiplegia (silent vs symptomatic1840 The Journal of Thoracic and Cardiovascular Surembolism, 18 vs 12 patients; P ¼ .69). Seizures were
observed in 39 patients (15 vs 24 patients; P ¼ .73). A total
of 7 patients had severe intracerebral bleeding (2%; 3 vs 4
patients; P ¼ .71). From these 7 patients, 3 died within 30
days after the operation, with 1 receiving acute craniotomy
for decompression. Another patient needed decompressive
craniotomy due to cerebral edema. Three patients were
managed medically, with 1 patient experiencing permanent
hemiparesis; 1 patient presented with recurrent epileptic
seizures and was treated medically.Long-Term Survival and Risk Factors for Long-Term
Death
Long-term survival was significantly influenced by cere-
bral embolism. Patients with preoperative cerebral embo-
lism had a 5-year survival of 46%  3% compared with
57%  2% in patients without cerebral embolism
(P< .01). Long-term survival after 10 years was 42% 
2% versus 35%  4%, respectively (P < .01) (see
Figure 1).
However, long-term survival was not influenced by pre-
operative symptomatology, but by the sole presence of cere-
bral embolism: patients with silent cerebral embolism had
an equally reduced short- and long-term mortality
compared with patients with preoperative neurologic symp-
toms. There were no significant differences comparing
short-term survival after 1 year (56%  5% vs 59% 
3% for silent vs symptomatic embolism; P ¼ .77) and
long-term survival after 5 years (45%  5% vs 47% 
4% for silent vs symptomatic embolism; P ¼ .83) andgery c June 2014
FIGURE 2. Long-term survival in patients with silent cerebral embolism
or transient ischemic attack (TIA) (blue line) compared with patients symp-
tomatic cerebral embolism (red line).
FIGURE 3. Freedom from reoperation.
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atic embolism; P¼ .86) (see also Figure 2). Risk factors for
long-term death in patients with cerebral embolism were
cardiopulmonary bypass time (P<.01), preoperative dial-
ysis (P< .01), low cardiac output syndrome (P ¼ .01),
age at surgery (P<.01), and chronic obstructive pulmonary
disease (P ¼ .03).
Considering all patients with cerebral embolism
receiving either biological or mechanical valve replace-
ment, survival was not statistically different between pa-
tients with mechanical valve (n ¼ 94) replacement
compared with biological valve replacement (n ¼ 266),
with a cumulative 10-year survival of 22%  7% versus
43%  6% (P ¼ .77). However, excluding patients who
died within 30 days or before hospital discharge, patients
receiving a mechanical valve (n ¼ 74 vs n¼ 206 biological
valves) clearly had a favorable long-term survival (29% 
9% vs 55%  7% after 10 years, mechanical vs biological
valve replacement; P ¼ .04), but patients receiving a me-
chanical valve were also significantly younger than their
peers who received a bioprosthetic valve (65.4  11.9 vs
53.7  12.6 years; P<.01).
In patients receiving aortic valve replacement only, there
was no difference in cumulative survival between patients
with a biological valve versus patients with a mechanical
valve (34%  8% vs 49%  10% after 10 years;
P ¼ .34; excluding hospital mortality, 42%  10% vs
59%  12% after 10 years; P ¼ .27).The Journal of Thoracic and CarFreedom From Reoperation
Freedom from reoperation in patients with septic cerebral
embolism was 92% 3% after 5 years and 83% 9% af-
ter a follow-up period of 10 years (see Figure 3). A total of
13 patients needed reoperation due to prosthetic valve endo-
carditis at a mean of 2.08  3.65 years (median, 5 months).DISCUSSION
Cerebrovascular complications of infective endocarditis
are frequent.1 The rate of cerebrovascular complications
in our study cohort was 24% (375 out of 1571 patients),
which is consistent with previously published studies7,8:
Thuny and colleagues2 found a rate of cerebrovascular com-
plications of 22.2% in their cohort of 496 patients, with no
difference in prosthetic versus native valve endocarditis.
They also found that cerebrovascular complications were
more frequent in patients with mitral valve endocarditis,
which is also consistent with our results becausemitral valve
endocarditis had the highest OR for cerebral embolism (OR,
2.76; 95% CI, 1.82-4.20; P<.01). In concordance with pre-
viously published studies, the risk for cerebral embolism
was higher in patients with mitral valve endocarditis than
aortic valve endocarditis (OR, 2.43; 95% CI, 1.58-3.72).9
The rate of symptomatic cerebral embolism was 64%
(240 out of 375 patients) in our institutional cohort.
In our study cohort, risk factors for cerebral embolism
were endocarditis of the mitral valve and/or the aortic valve,
vegetation size> 10 mm, preoperatively initiated empiric
antibiotic therapy, and S aureus. Various risk factors we
found have been previously described. In 2004, Deprele
and colleagues10 and Thuny and colleagues11 also founddiovascular Surgery c Volume 147, Number 6 1841
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ated with systemic embolism and Di Silva and colleagues12
underlined that large vegetations>15 mm predict an even
higher risk of embolization. In addition, Heiro and
colleagues7 and Corral and colleagues8 found that S aureus
is significantly associated with cerebral complications in
infective endocarditis.
Our study cohort shows a clear predominance of
biological valves compared with mechanical valves. In
past years, the implantation of biological valves in patients
with AIE has been preferred according to our institutional
policy. Commonly, biological valves are preferred if
cerebral septic embolic lesions are present because
anticoagulation regimens do not have to be as strict as in
mechanical heart valves, in particular if hemorrhagic
transformation of a cerebral infarction is observed
postoperatively. Generally, patients with biological heart
valves are administered aspirin 100 mg daily and intrave-
nous heparin (partial thromboplastin time, 60-80 seconds)
until they are transferred to the general ward and unless
there are relevant bleeding complications. Afterward,
recipients of biological valves are administered phenpro-
coumon for 2 to 3 months in the absence of contraindica-
tions. Mechanical heart valves are generally treated with
the anticoagulant intravenous heparin (partial thrombo-
plastin time 60-80 seconds) until transferred to the general
ward and followed with lifelong anticoagulation therapy.
Interestingly, prosthetic valve endocarditis was not asso-
ciated with a higher incidence of cerebral embolism
compared with native valve endocarditis (native valve endo-
carditis, 24.1% vs prosthetic valve endocarditis, 23.5%;
P ¼ .89). These findings correspond to Delahaye and col-
leagues13 who also found no difference in the rate of cere-
brovascular events in native versus prosthetic valve
endocarditis.
Furthermore, it was previously hypothesized that older
patients might have a higher risk for systemic embolism
due to preexisting vascular disease.5 Interestingly, patients
with septic cerebral embolism were not significantly older
than patients without cerebral embolism in our study
(61.8  13.6 vs 61.5  15.2 years; P ¼ .78).
Moreover, we found that preoperative antibiotic treat-
ment was a significant risk factor for cerebral embolism
in our cohort (OR, 1.91; 95% CI, 1.27-2.87; P< .01). A
possible explanation is that preoperative antibiotic therapy
in patients with left-sided endocarditis and large vegetations
may lead to a fragmentation of the vegetations and consec-
utively lead to a higher incidence of systemic embolism.
Unfortunately, it was not possible to retrospectively obtain
reliable data about the exact duration of preoperative antibi-
otic therapy.
In 2002 Vilacosta and colleagues9 found 65% of embolic
events that occurred during antibiotic therapy were detected
during the first 2 weeks after initiation of the antimicrobial1842 The Journal of Thoracic and Cardiovascular Surtreatment—a striking finding that has to be verified by
future prospective studies, because it is a clue that the dog-
matic principle of ‘‘hit hard and early’’ in the antibiotic ther-
apy of AIE with large vegetations might be open for debate
and puts more emphasis on early surgical therapy. However,
among patients who had not received preoperative empiric
intravenous antibiotic therapy, the proportion of patients
with vegetations>10 mm was significantly lower (86 out
of 311 patients vs 853 out of 1260 patients; P<.01), indi-
cating that there might be a higher proportion of subacute
or subsided endocarditis in this group, who were in part in-
traoperatively diagnosed as having endocarditis.
Cerebral embolism was significantly associated with a
higher incidence of lesions to the spleen and the kidneys,
whereas pulmonary lesions were much less frequent. Apart
from the fact that tricuspid valve endocarditis has a higher
incidence of pulmonary embolism, these findings suggest
that cerebral embolism is often an expression of a generally
septic course of endocarditis. Given the fact that most pa-
tients with cerebral lesions died from sepsis with multior-
gan failure, sepsis seems to be more threatening to
patients than hemorrhagic transformation of a septic
embolic cerebral stroke.
Hospital mortality in our high-risk cohort was 22%—still
high, but comparable to previously published studies. The
main reason for perioperative death was septic shock with
consecutive multiorgan failure. Generally, the occurrence
of sepsis hemodynamics seems to be a main predictor for
short- and long-term outcome. In a previously published
study from Ruttmann and colleagues,14 sepsis was the
main reason for hospital death. Hill and colleagues15 also
found septic shock and S aureus infection were significantly
associated with 6-month mortality. These findings empha-
size the importance of preventing septic dissemination of
the vegetations, either by early operative treatment and/or
by early and aggressive antimicrobial treatment.
We observed only 7 patients (2%) with severe postoper-
ative intracerebral bleeding with only 2 patients dying
within the first 30 days, which is a remarkably low rate
and much lower than we expected. However, Ruttmann
and colleagues14 also found only 1 of 65 patients with septic
cerebral embolism dying from postoperative intracerebral
hemorrhage, so the risk of fatal perioperative cerebral
bleeding as a result of anticoagulation during cardiopulmo-
nary bypass might be commonly overestimated. Yoshioka
and colleagues16 reported only 1 silent hemorrhagic trans-
formation of a cerebral septic embolic infarction in their
study cohort of 64 patients. Various reasons for the benefi-
cial neurologic outcome after septic embolic stroke have
been previously discussed: Ruttmann and colleagues14 hy-
pothesized that anticoagulation during cardiopulmonary
bypass might lead to fragmentation and a more peripheral
dislocation of the embolus, explaining a relatively good
neurologic outcome. They argue that patients with septicgery c June 2014
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status than the typical patient experiencing a stroke. How-
ever in patients with infective endocarditis, cerebral micro-
bleeding detected by magnetic resonance scans are thought
to be indicators of poor vascular status and therefore might
be predictive for intracranial hemorrhage.17 Yoshioka and
colleagues16 stated that reperfusion injury is less likely to
occur because bacterial embolism was unlikely to be lysed
due to a specific thrombus composition.
Despite improvements in diagnostics and therapy, pa-
tients with AIE still have a poor long-term prognosis, which
is even inferior in patients with septic cerebral embolism. In
our study, patients with cerebral lesions showed a 5-year sur-
vival of 46%  3% compared with 57%  2% in patients
without cerebral embolism (P<.01), with a 10-year survival
after 10 years of 42% 2% versus 35% 4%, respectively
(P<.01). However, we did not find a significant difference
with regard to long-term survival in patients with preopera-
tive symptomatic versus silent embolism. In contrast, Thuny
and colleagues2 found a significantly better long-term sur-
vival in patients with silent embolism or transient ischemic
attack compared with symptomatic embolism. This might
be due to different diagnostic criteria. Our definition criteria
of symptomatic embolism also included patients with un-
specific symptoms such as an altered level of consciousness
or headache because thesemight be clinical decision criteria
to rule out septic embolism byCTormagnetic resonance im-
aging. In a prospective study from Chu and colleagues,18
septic embolism was an important predictor of early mortal-
ity, but the rate of patients receiving surgery for infective en-
docarditis was only 27%.
Risk factors for long-term death in patients with cerebral
embolism were cardiopulmonary bypass time (P< .01),
preoperative dialysis (P< .01), low cardiac output syn-
drome (P ¼ .01), age at surgery (P< .01), and chronic
obstructive pulmonary disease (P ¼ .03).
These risk factors reflect common risk factors for mortal-
ity in patients undergoing cardiac surgery. Most of them are
patient-related and not modifiable; that is, cannot be influ-
enced by the surgeon. Even cardiopulmonary bypass time
is to be considered as an indicator for the complexity of the
required operation (eg, complicated by intraoperative find-
ings, excessive tissue destruction, fragile tissue, and abscess
formation).However,we believe that low cardiac output syn-
drome is either a sign of septic cardiomyopathy or excessive
valve destruction leading to significant valve regurgitation,
which indicates that these patients would probably have
benefited from earlier referral to a cardiac surgeon.
Our data do not support the notion that delaying or avoid-
ing surgery in high-risk patients results in better survival.
Limitations
The results of our study may be subject to various selec-
tion biases, such as patients with large cerebral infarction orThe Journal of Thoracic and Carsevere preoperative intracranial hemorrhage detected by
preoperative routine CT scans were considered not suitable
for surgery and were possibly not referred to our hospital
during the acute phase. Furthermore, the time from onset
of the symptoms until surgery may pose a confounding
variable that could not be sufficiently detected during
retrospective analysis. Due to this fact, it is not possible
to determine the optimal timing for heart valve surgery after
a cerebrovascular event has occurred because of septic
embolism. However, this was not the subject of our study,
but this important fact remains to be clarified. Several
authors propose a safe interval for surgical therapy, which
is either in the first 72 hours after onset of an embolic event
or otherwise after a delay of 4 weeks.19-21
Septic cerebral embolism was generally ruled out by
preoperative routine CT scans, not by magnetic resonance
imaging, which might be more sensitive in the early phase
of an acute ischemic stroke. Because it is known that
ischemic cerebral lesions show a time latency of about 2
to 6 hours after they can be identified in cerebral CT scans,22
some septic embolic events may have been missed if
the CT scans were obtained during the early phase.
Furthermore, magnetic resonance imaging seems to be
more sensitive in detecting cerebral embolism compared
with CT studies, resulting in a far higher incidence of acute
brain embolization in infective endocarditis than previously
assumed.1,23,24 Moreover, we did not perform cerebro-
spinal fluid analyses for neurochemical markers of acute
brain damage because lumbar punctures preceding full
heparinization for cardiopulmonary bypass may pose a
high risk for spinal hematoma with devastating
consequences and their clinical relevance is doubtful.
Moreover, because we are a tertiary reference center for
cardiac surgery, our patients were not routinely seen by an
experienced neurologist before the surgical intervention,
so some patients might have been mistakenly assigned to
the silent embolism group despite presenting with latent
neurologic symptoms.
CONCLUSIONS
In patients with infective endocarditis, silent cerebral
embolism can frequently be detected by routine
preoperative CT scans and is a predictor of an unfavorable
short- and long-term outcome. Because long-term survival
in patients with cerebral embolism is independent from
actual symptomatology, routine preoperative CT or
magnetic resonance scans are necessary to detect silent
embolism. Particularly in patients with a vegetation
sized>10 mm and blood cultures positive for S aureus,
cerebral CT scans are mandatory to rule out septic
cerebral embolism.
Patients with either symptomatic or asymptomatic embo-
lism have to be closelymonitored to early detect hemorrhag-
ic transformation and consecutively adjust anticoagulationdiovascular Surgery c Volume 147, Number 6 1843
Acquired Cardiovascular Disease Misfeld et al
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Dregimens.We also recommendneurologic consultation in all
patients with cerebral embolism, in particular if hemorrhag-
ic transformation or intracranial bleeding has occurred.
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Dr Marc Ruel (Ottawa, Canada). Dr Misfeld and colleagues
have presented their findings in 375 patients who had surgery
for acute infective endocarditis preoperatively complicated by
cerebral embolism over an 18-year period. This subpopulation
represents roughly a quarter of their operations for infective
endocarditis. The work contains interesting descriptive
information, some of which I will comment on.
When dealing with infective endocarditis there are essentially
2 questions: what technique to do and when to do it. We are getting
much better at answering the first question. We have better antibi-
otics, better hemodynamic treatments, and we know that homo-
grafts are not mandatory, which was confirmed once more in
your study where they were used relatively infrequently. And we
also know that stroke is not a contraindication to surgery. Never-
theless, the perioperative mortality of these operations remains
high, and in your study it was 22%, which is not out of range
but still high indeed.
When to intervene remains the big question. You have shown
that 135 patients, representing roughly 9% of all your operated
infective endocarditis patients, and 36% of the cerebral embolism
subcohort, had asymptomatic cerebral embolism. One of your con-
clusions is that preoperative cerebral imaging is therefore of great
importance. However, it remains to be determined to what extent
cerebral imaging changes the management, provided that you do
not find shift or a bleed on the computed tomography (CT) scan
or magnetic resonance imaging scan.
There are other groups, such as the 1 from Osaka University
presented last year, who found that perioperative hemorrhagic
transformation of a stroke is relatively rare, and you have found
this as well. But I believe that surgeons need to know if there
are characteristics or predictors of what may lead to hemorrhagic
transformation or cause significant brain edema with surgery.
There are groups, for instance, who have used an algorithm
where surgery is delayed if a brain infarct with mass effect is found
on head CT, or if there is an unruptured mycotic aneurysm present
that would be clipped before surgery.
It is clear that more and more research points toward early sur-
gical intervention in the case of infective endocarditis with cere-
bral embolization, on the basis that it does not increase mortality
and may help prevent subsequent stroke.gery c June 2014
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DHere you make no claim, but you point out that preoperative
antibiotic therapy was independently associated with cerebral em-
bolism and, therefore, one should proceed to surgery quickly.
Recent work from the International Collaboration on Endocarditis
revealed a trend toward higher in-hospital mortality when surgery
was performed within 7 days of the stroke at a 22% rate, versus
only 12% when surgery was delayed to a later date.
There has to be some prognostic determinants related to the
brain imaging, to the causative organism, to the status of the pa-
tient, to the valve itself, to the vegetations and their size, or to
the hemodynamics that we just do not know and need to elucidate.
Your research is a step in the right direction, but these many ques-
tions remain.
I have 2 questions. First, do you use the results of the head CT
scan or magnetic resonance imaging scan as mere prognostic in-
formation for the patient and family, or are there some character-
istics that are looked for to delay or perhaps in some cases expedite
surgical intervention?
My second question is related to the first. Clearly not everyone
who has a cerebral embolism and infective endocarditis has to un-
dergo operation; for instance, in previous research only 23% did.
Many patients are fine just with medical treatment. What are the
patient or brain lesion characteristics that would entice you to op-
erate right away versus waiting, perform another intervention such
as neurosurgery first, or not operate at all. For instance, if a patient
is stable with a smaller lesion but has infective endocarditis and ce-
rebral embolism?
DrMisfeld. Indication in Leipzig for performing surgery in this
group of patients is always an individual decision and probably
there are 4 aspects that are important.
First, the clinical presentation: What kind of neurologic compli-
cation is present? Does the patient have low cardiac output? Status
of the other organ systems is important, too. Second, the therapeu-
tic regimen at presentation: Howmany inotropes is the patient tak-
ing and what about the antibiotic regimen? For how long has the
patient been taking antibiotics and what kind of bacteria have
been cultured? Third, the echo images are most important, and it
is probably not only the size of the vegetation, it is especially
the characteristics of the vegetation; mobility, for example. Addi-
tional questions have to be answered: are there multiple vegeta-
tions, are both valves affected, and is an abscess present? This
will all be part of the final decision, as well as the fourth aspect,
the CT scan or magnetic resonance imaging findings. We routinely
perform not only a CT scan of the brain, but also of thewhole body.
With regard to the cranial CT scan we have some sort of insen-
sitivity within the first time after a stroke where the lesions in the
brain are probably not demarked and therefore not visible. You are
also probably not able to detect microbleeds with the CT scan as
you can do with magnetic resonance imaging. Microbleeds have
been proposed to be a risk factor for later cerebral bleeding. How-
ever, CT scans are fast to perform and available everywhere.
I will give you an example. In a patient with a vegetation of
5 mm who has experienced a stroke, we would look at the kind
of vegetation: Is it mobile? We would also look at the CT scan.
If there is no lesion, but a clinical presentation of stroke, a surgeon
is probably within this range of safety (before 72 hours) where the
ischemic region has not been transformed with the potential risk of
hemorrhage. In that patient, we would perform the surgery as soonThe Journal of Thoracic and Caras possible. Some even advocate that in a patient like this surgery
may be protective against stroke by using a heart-lung-machine
with hemodilation, hypothermia, and anticoagulation.
If that patient presents with a stroke and a lesion on the brain, it
depends on the location and the size of the cerebral defect. It has
been suggested that small-size lesions are probably safe, whatever
‘‘small’’ means, so probably 1 to 1.5 cm2 is a small lesion. The
location of the lesion is also important. Is it more peripheral or cen-
tral and are there multiple lesions or not?
It is also most important to consult a radiologist; a cardiologist;
and, if there is a hemorrhagic transformation, the neurosurgeon. In
the end it will be a team decision.
If there is a bigger lesion or multiple small lesions and already a
shift in the brain’s midline or an edema, you probably need to post-
pone the procedure. We would also postpone surgery in the pres-
ence of a hemorrhagic transformation.
At 1 stage you need to balance the increasing the risk of cerebral
complications versus the risk of the operation itself. In these pa-
tients we watch and wait; we closely follow them clinically, with
CT scans and echo. In some patients who had a hemorrhagic trans-
formation and you postpone surgery, it ends up in an ethical ques-
tion of if you operate or not.
Dr Antonio Laudito (Duluth, Minn). I have a question on the
temporal pattern of embolization. Considering your experience
and your review of the literature, are the patients embolizing in
the first 48 hours or, as you say, 72 hours, and then the rate of
embolization goes down? Could you confirm that kind of clinical
scenario and temporal pattern of embolization?
Dr Misfeld. Usually we see the patients very late. We see pa-
tients who already have an abscess or they have embolized or
they have experienced a stroke and then we see them after 1 or 2
weeks.
There is decreasing risk of stroke over time. If a patient has
experienced a stroke once and is following a proper antibiotic
treatment, probably the risk of re-stroke is less than assumed.
Dr Thierry Mesana (Ottawa, Canada). Do you have a
particular recommendation for a prosthetic valve in these patients?
How often would you put in a mechanical valve, and how do you
manage anticoagulation in these patients after surgery?
DrMisfeld.We follow the principle: Be radical and repair what
you have to repair. The other principle is that we aim to drain the
pus if there is an abscess into the mediastinum. So try to avoid
patching abscesses.
It is not as important what kind of valve type you use. If there
is a hemorrhagic transformation before the operation or a very
high risk for that, we choose a biological valve—not a mechan-
ical valve—to avoid anticoagulation. Age is not an issue for us
with regard to valve choice. The patients have to survive the
endocarditis.
We still use the homograft because we believe that without any
artificial material, at least theoretically, this has some benefit with
regard to the risk of reinfection. My advice is that you probably
should stick to the valve type or the procedure you are used to.
If you have never used a homograft before, you probably should
not use a homograft in an endocarditis scenario with root abscess.
If the endocarditis only affects the cusps of the aortic valve, and
there is no brain lesion or hemorrhage, then we would follow our
normal regimen of putting in biological or mechanical valves.diovascular Surgery c Volume 147, Number 6 1845
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patients?
Dr Misfeld. No, but our overall number of mechanical valves
for younger patients without endocarditis is already very, very low.
Dr Harold Lazar (Boston, Mass). I have 1 final question. I
wholeheartedly agree with you about running patients through a
scanner when they come in with endocarditis. I have always
been amazed to see other areas. How often have you seen other
embolic sites associated with cerebral emboli? How often do
you see it just as 1 area? In the presence of multiple emboli,1846 The Journal of Thoracic and Cardiovascular Surmultiple systems involved, the brain, spleen, usually kidney, would
that make you want to operate earlier than if you just saw 1 isolated
area?
DrMisfeld. Excellent question. If there is no lesion of the brain
but emboli are present in the spleen and kidney, for example, then
you can assume that probably emboli are present in the brain that
have not been detected yet by CT scan or they are too small. In
more than one-third of cases we were able to find spleen emboli-
zation or abscesses and we had to take the spleen out in one-third
of these patients.gery c June 2014
